Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Med (New York, N.Y.)|July 5, 2021
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health systemColin Pawlowski, Patrick Lenehan, Arjun Puranik, et al.Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalenceArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.NPJ Systems Biology and Applications|November 28, 2024
A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variantsRobert P Matson, Isin Y Comba, Eli Silvert, et al.PNAS Nexus|January 30, 2023
Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infectionMichiel J M Niesen, Robert Matson, Arjun Puranik, et al.PNAS Nexus|July 14, 2022
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19Arjun Puranik, Patrick J Lenehan, John C O'Horo, et al.Medrxiv : the Preprint Server for Health Sciences|December 16, 2022
Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditionsPritha Ghosh, Michiel J M Niesen, Colin Pawlowski, et al.Iscience|July 31, 2024
Case-control study on post-COVID-19 conditions reveals severe acute infection and chronic pulmonary disease as potential risk factorsPritha Ghosh, Michiel J M Niesen, Colin Pawlowski, et al.Med (New York, N.Y.)|December 20, 2021
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.JAMA Network Open|April 14, 2022
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health RecordsMichiel J M Niesen, Colin Pawlowski, John C O'Horo, et al.Pageof 8